191 related articles for article (PubMed ID: 7507413)
21. Effect on the expression of c-met, c-myc and PPAR-alpha in liver and liver tumors from rats chronically exposed to the hepatocarcinogenic peroxisome proliferator WY-14,643.
Miller RT; Glover SE; Stewart WS; Corton JC; Popp JA; Cattley RC
Carcinogenesis; 1996 Jun; 17(6):1337-41. PubMed ID: 8681452
[TBL] [Abstract][Full Text] [Related]
22. Dose-related effects of the hepatocarcinogen, Wy-14,643, on peroxisomes and cell replication.
Wada N; Marsman DS; Popp JA
Fundam Appl Toxicol; 1992 Jan; 18(1):149-54. PubMed ID: 1601204
[TBL] [Abstract][Full Text] [Related]
23. Enhancement of peroxisomal enzymes, cytochrome P-452 and DNA synthesis in putative preneoplastic foci of rat liver treated with the peroxisome proliferator nafenopin.
Grasl-Kraupp B; Huber W; Just W; Gibson G; Schulte-Hermann R
Carcinogenesis; 1993 May; 14(5):1007-12. PubMed ID: 8099311
[TBL] [Abstract][Full Text] [Related]
24. Cyclosporine stimulates hepatocyte proliferation and accelerates development of hepatocellular carcinomas in rats.
Masuhara M; Ogasawara H; Katyal SL; Nakamura T; Shinozuka H
Carcinogenesis; 1993 Aug; 14(8):1579-84. PubMed ID: 8353842
[TBL] [Abstract][Full Text] [Related]
25. Induction of a 65-kDa tumor-associated protein in altered hepatic foci of rats fed the peroxisome proliferator Wy-14,643.
Hanausek M; Sherman U; Mirowski M; Adams AK; Walaszek Z
Prog Clin Biol Res; 1994; 387():337-48. PubMed ID: 7972257
[No Abstract] [Full Text] [Related]
26. Inhibition of WY-14,643 induced hepatic lesion growth in mice by rotenone.
Isenberg JS; Kolaja KL; Ayoubi SA; Watkins JB; Klaunig JE
Carcinogenesis; 1997 Aug; 18(8):1511-9. PubMed ID: 9276624
[TBL] [Abstract][Full Text] [Related]
27. Increased resistance of peroxisome proliferator-induced hepatic lesions to iron overload in rats.
Rao MS; Subbarao V; Reddy JK
Cancer Lett; 1986 Jul; 32(1):33-9. PubMed ID: 3742486
[TBL] [Abstract][Full Text] [Related]
28. NTP Toxicology and Carcinogenesis Studies of 1-Amino-2,4-Dibromoanthraquinone (CAS No. 81-49-2) in F344/N Rats and B6C3F1 Mice (Feed Studies).
National Toxicology Program
Natl Toxicol Program Tech Rep Ser; 1996 Aug; 383():1-370. PubMed ID: 12692653
[TBL] [Abstract][Full Text] [Related]
29. Decreased hepatocyte growth factor level by Wy-14,643, non-genotoxic hepatocarcinogen in F-344 rats.
Motoki Y; Tamura H; Morita R; Watanabe T; Suga T
Carcinogenesis; 1997 Jul; 18(7):1303-9. PubMed ID: 9230272
[TBL] [Abstract][Full Text] [Related]
30. Analysis of peroxisome proliferator-induced preneoplastic and neoplastic lesions of rat liver for placental form of glutathione S-transferase and gamma-glutamyltranspeptidase.
Rao MS; Tatematsu M; Subbarao V; Ito N; Reddy JK
Cancer Res; 1986 Oct; 46(10):5287-90. PubMed ID: 2875789
[TBL] [Abstract][Full Text] [Related]
31. Increased nuclear ploidy, not cell proliferation, is sustained in the peroxisome proliferator-treated rat liver.
Lalwani ND; Dethloff LA; Haskins JR; Robertson DG; de la Iglesia FA
Toxicol Pathol; 1997; 25(2):165-76. PubMed ID: 9125775
[TBL] [Abstract][Full Text] [Related]
32. Inhibition of hepatocarcinogenesis by the deletion of the p50 subunit of NF-kappaB in mice administered the peroxisome proliferator Wy-14,643.
Glauert HP; Eyigor A; Tharappel JC; Cooper S; Lee EY; Spear BT
Toxicol Sci; 2006 Apr; 90(2):331-6. PubMed ID: 16434500
[TBL] [Abstract][Full Text] [Related]
33. Biochemical microanalysis of pyruvate kinase activity in preneoplastic and neoplastic liver lesions induced in rats by N-nitrosomorpholine.
Klimek F; Bannasch P
Carcinogenesis; 1990 Aug; 11(8):1377-80. PubMed ID: 2387024
[TBL] [Abstract][Full Text] [Related]
34. Sequential appearance and ultrastructure of amphophilic cell foci, adenomas, and carcinomas in the liver of male and female rats treated with dehydroepiandrosterone.
Metzger C; Mayer D; Hoffmann H; Bocker T; Hobe G; Benner A; Bannasch P
Toxicol Pathol; 1995; 23(5):591-605. PubMed ID: 8578102
[TBL] [Abstract][Full Text] [Related]
35. Relationship of oxidative damage to the hepatocarcinogenicity of the peroxisome proliferators di(2-ethylhexyl)phthalate and Wy-14,643.
Conway JG; Tomaszewski KE; Olson MJ; Cattley RC; Marsman DS; Popp JA
Carcinogenesis; 1989 Mar; 10(3):513-9. PubMed ID: 2924396
[TBL] [Abstract][Full Text] [Related]
36. Cell proliferation and regulation of negative growth factors in mouse liver foci.
Moser GJ; Wolf DC; Harden R; Standeven AM; Mills J; Jirtle RL; Goldsworthy TL
Carcinogenesis; 1996 Sep; 17(9):1835-40. PubMed ID: 8824503
[TBL] [Abstract][Full Text] [Related]
37. Dietary glycine prevents increases in hepatocyte proliferation caused by the peroxisome proliferator WY-14,643.
Rose ML; Germolec D; Arteel GE; Schoonhoven R; Thurman RG
Chem Res Toxicol; 1997 Oct; 10(10):1198-204. PubMed ID: 9348444
[TBL] [Abstract][Full Text] [Related]
38. Induction of altered hepatic foci in rats by the administration of hypolipidemic peroxisome proliferators alone or following a single dose of diethylnitrosamine.
Glauert HP; Beer D; Rao MS; Schwarz M; Xu YD; Goldsworthy TL; Coloma J; Pitot HC
Cancer Res; 1986 Sep; 46(9):4601-6. PubMed ID: 2873887
[TBL] [Abstract][Full Text] [Related]
39. Lack of expression of glutathione-S-transferase P, gamma-glutamyl transpeptidase, and alpha-fetoprotein messenger RNAs in liver tumors induced by peroxisome proliferators.
Rao MS; Nemali MR; Usuda N; Scarpelli DG; Makino T; Pitot HC; Reddy JK
Cancer Res; 1988 Sep; 48(17):4919-25. PubMed ID: 2457433
[TBL] [Abstract][Full Text] [Related]
40. Failure of the peroxisome proliferator WY-14,643 to initiate growth-selectable foci in rat liver.
Cattley RC; Marsman DS; Popp JA
Toxicology; 1989 May; 56(1):1-7. PubMed ID: 2728002
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
